Icon

AIRSUPRA (NDA214070)- (EQ 0.09MG BASE/INH;0.08MG/INH)

ALBUTEROL SULFATE; BUDESONIDE ASTRAZENECA
EQ 0.09MG BASE/INH;0.08MG/INH
No Yes
2030-May-28 Expired
None 2026-Jan-10
None No
AIRSUPRA is a combination of albuterol, a beta2-adrenergic agonist and budesonide, a corticosteroid, indicated for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years of age and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 0.09MG BASE/INH;0.08MG/INH ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.